Last updated on July 2018

Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study


Brief description of study

This study will provide continuing availability to tazemetostat as a single agent to subjects who have completed their participation in an antecedent tazemetostat study (either with monotherapy or combination therapy). In addition, long-term safety and overall survival will be collected.

Clinical Study Identifier: NCT02875548

Contact Investigators or Research Sites near you

Start Over

Epizyme

Tucson, AZ United States
  Connect »

Epizyme

Bordeaux, France
  Connect »

Epizyme

Montpellier, France
  Connect »

Epizyme

Villejuif Cedex, France
  Connect »

Epizyme

New York, NY United States
  Connect »

Epizyme

Lille, France
  Connect »

Epizyme

Rouen, France
  Connect »

Epizyme

Leicester, United Kingdom
  Connect »

Epizyme

London, United Kingdom
  Connect »

Epizyme

Clayton, Australia
  Connect »

Epizyme

East Melbourne, Australia
  Connect »

Epizyme

Pierre-Bénite, France
  Connect »